Researchers have shown for the first time that a crucial interface in a protein that drives cancer growth could act as a target for more effective treatments.
TNF Blockers for IBD Tied to Risk for Immune-Mediated Diseases
Treating inflammatory bowel disease (IBD) with tumor necrosis factor (TNF) inhibitors was paradoxically associated with an increased risk for other immune-mediated inflammatory diseases (IMIDs) in